Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial.
Sigurgeirsson B, Boznanski A, Todd G, Vertruyen A, Schuttelaar ML, Zhu X, Schauer U, Qaqundah P, Poulin Y, Kristjansson S, von Berg A, Nieto A, Boguniewicz M, Paller AS, Dakovic R, Ring J, Luger T. Sigurgeirsson B, et al. Pediatrics. 2015 Apr;135(4):597-606. doi: 10.1542/peds.2014-1990. Epub 2015 Mar 23. Pediatrics. 2015. PMID: 25802354 Free article. Clinical Trial.
Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.
Sigurgeirsson B, Ho V, Ferrándiz C, Andriano K, Grinienko A, Jimenez P; Pimecrolimus 1% cream in (paediatric) Eczema: Prevention of Progression multi-centre investigator study group. Sigurgeirsson B, et al. J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1290-301. doi: 10.1111/j.1468-3083.2008.02785.x. Epub 2008 Jul 24. J Eur Acad Dermatol Venereol. 2008. PMID: 18624866 Clinical Trial.
Authors' Response.
Sigurgeirsson B, Luger T. Sigurgeirsson B, et al. Pediatrics. 2015 Nov;136(5):e1485-6. doi: 10.1542/peds.2015-2785B. Pediatrics. 2015. PMID: 26527086 No abstract available.
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.
Langley RG, Sofen H, Dei-Cas I, Reich K, Sigurgeirsson B, Warren RB, Paul C, Szepietowski JC, Tsai TF, Hampele I, You R, Charef P, Papavassilis C. Langley RG, et al. Among authors: sigurgeirsson b. Br J Dermatol. 2023 Feb 10;188(2):198-207. doi: 10.1093/bjd/ljac040. Br J Dermatol. 2023. PMID: 36763857 Clinical Trial.
Combination therapy for onychomycosis.
Olafsson JH, Sigurgeirsson B, Baran R. Olafsson JH, et al. Among authors: sigurgeirsson b. Br J Dermatol. 2003 Sep;149 Suppl 65:15-8. doi: 10.1046/j.1365-2133.149.s65.2.x. Br J Dermatol. 2003. PMID: 14510971 Review.
119 results